Logo

Euformatics Joins Global Alliance for Genomics and Health

Nov 06, 2014 | staff reporter

NEW YORK (GenomeWeb) – Finnish bioinformatics firm Euformatics today said that it has joined the Global Alliance for Genomics and Health.

Euformatics provides tools for interpreting genomic data and to assist physicians and molecular genetics laboratories in delivering precision medicine, it said on its website. Last month, Euformatics and BC Platforms announced a strategic partnership to embed Euformatics' OmnomicsNGS software in BC's Enterprise solution in order to improve the analysis of the genetic basis of diseases.

The Global Alliance for Genomics and Health seeks to accelerate genomic medicine to improve human health. Earlier this week, SRA International said that it had joined the alliance.

Filed under

Informatics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.